• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺增生症中的炎症模式:一项组织学和细菌学研究。

Patterns of inflammation in prostatic hyperplasia: a histologic and bacteriologic study.

作者信息

Kohnen P W, Drach G W

出版信息

J Urol. 1979 Jun;121(6):755-60. doi: 10.1016/s0022-5347(17)56980-3.

DOI:10.1016/s0022-5347(17)56980-3
PMID:88527
Abstract

In a series of 162 cases of surgically resected hyperplastic prostates the incidence of inflammation is 98.1%. Six morphologic patterns of inflammation are described: 1) segregated glandular inflammation, 2) periglandular inflammation, 3) diffuse stromal inflammation, 4) isolated stromal lymphoid nodules, 5) acute necrotizing inflammation and 6) focal granulomatous inflammation. The most common pattern, segregated glandular inflammation, is characterized by intraluminal neutrophils and foamy macrophages and by chronic inflammatory cells in the surrounding stroma. No significant morphological differences are found among groups of cases with positive and negative evidence by culture of bacterial prostatic infection. Quantitative but not qualitative morphologic differences are found between cases of gram-negative infections and infection by gram-positive organisms that often are considered non-pathogens.

摘要

在一系列162例手术切除的增生性前列腺病例中,炎症发生率为98.1%。描述了六种炎症形态模式:1)分离性腺管炎症,2)腺管周围炎症,3)弥漫性间质炎症,4)孤立性间质淋巴小结,5)急性坏死性炎症和6)局灶性肉芽肿性炎症。最常见的模式,即分离性腺管炎症,其特征是管腔内有中性粒细胞和泡沫状巨噬细胞,周围间质中有慢性炎症细胞。在前列腺细菌感染培养有阳性和阴性证据的病例组之间未发现明显的形态学差异。在革兰氏阴性菌感染病例与通常被认为是非病原体的革兰氏阳性菌感染病例之间发现了数量上而非质量上的形态学差异。

相似文献

1
Patterns of inflammation in prostatic hyperplasia: a histologic and bacteriologic study.前列腺增生症中的炎症模式:一项组织学和细菌学研究。
J Urol. 1979 Jun;121(6):755-60. doi: 10.1016/s0022-5347(17)56980-3.
2
Inflammation and glandular proliferation in hyperplastic prostates: association with prostate specific antigen value.增生性前列腺中的炎症和腺体增生:与前列腺特异性抗原值的关联。
Bangladesh Med Res Counc Bull. 2001 Dec;27(3):79-83.
3
Intraepithelial lymphocytes in relation to NIH category IV prostatitis in autopsy prostate.尸检前列腺中与美国国立卫生研究院IV类前列腺炎相关的上皮内淋巴细胞
Prostate. 2015 Jul 1;75(10):1074-84. doi: 10.1002/pros.22991. Epub 2015 Apr 27.
4
Inflammation and benign prostatic hyperplasia.炎症与良性前列腺增生
Urol Clin North Am. 2008 Feb;35(1):109-15; vii. doi: 10.1016/j.ucl.2007.09.012.
5
[Bacterial content of the enucleated prostate gland].[摘除前列腺的细菌含量]
Arch Esp Urol. 1999 Oct;52(8):823-34.
6
Inflammation in benign prostatic hyperplasia: correlation with prostate specific antigen value.良性前列腺增生中的炎症:与前列腺特异性抗原值的相关性。
J Urol. 1997 Apr;157(4):1301-3. doi: 10.1016/s0022-5347(01)64957-7.
7
Nonspecific inflammatory lesions of the prostate. Spectrum and patterns.前列腺的非特异性炎性病变。谱系与模式
Int Surg. 1975 Mar;60(3):158-62.
8
Characterisation of inflammatory cells in benign prostatic hyperplasia.良性前列腺增生中炎症细胞的特征分析
Acta Histochem. 1998 Nov;100(4):439-49. doi: 10.1016/S0065-1281(98)80040-8.
9
Role of inflammation in benign prostatic hyperplasia development among Han Chinese: A population-based and single-institutional analysis.炎症在汉族男性良性前列腺增生发展中的作用:一项基于人群和单机构的分析。
Int J Urol. 2015 Dec;22(12):1138-42. doi: 10.1111/iju.12914. Epub 2015 Aug 27.
10
Preexisting histologic evidence of prostatitis is unrelated to postimplant urinary morbidity.前列腺炎的既往组织学证据与植入术后泌尿系统发病率无关。
Int J Cancer. 2001;96 Suppl:79-82. doi: 10.1002/ijc.10351.

引用本文的文献

1
Lc-ms-based untargeted metabolomics reveals potential mechanisms of histologic chronic inflammation promoting prostate hyperplasia.基于液相色谱-质谱联用的非靶向代谢组学揭示了组织学慢性炎症促进前列腺增生的潜在机制。
PLoS One. 2024 Dec 23;19(12):e0314599. doi: 10.1371/journal.pone.0314599. eCollection 2024.
2
Asiatic acid mitigates testosterone-induced benign prostatic hyperplasia in rats via activation of PPAR-γ.齐墩果酸通过激活PPAR-γ减轻睾酮诱导的大鼠良性前列腺增生。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Feb;398(2):1991-2001. doi: 10.1007/s00210-024-03405-z. Epub 2024 Sep 2.
3
The relationship between complete blood cell count-derived inflammatory biomarkers and benign prostatic hyperplasia in middle-aged and elderly individuals in the United States: Evidence from NHANES 2001-2008.
美国中老年人群全血细胞计数衍生炎症生物标志物与良性前列腺增生的关系:来自 NHANES 2001-2008 的证据。
PLoS One. 2024 Jul 9;19(7):e0306860. doi: 10.1371/journal.pone.0306860. eCollection 2024.
4
Intrinsic and extrinsic factors causing hyperplasia of the prostate.导致前列腺增生的内在和外在因素。
Int J Urol. 2024 Jul;31(7):705-717. doi: 10.1111/iju.15446. Epub 2024 Mar 10.
5
Association between gut microbiota and benign prostatic hyperplasia: a two-sample mendelian randomization study.肠道微生物群与良性前列腺增生的关联:一项两样本孟德尔随机化研究。
Front Cell Infect Microbiol. 2023 Sep 20;13:1248381. doi: 10.3389/fcimb.2023.1248381. eCollection 2023.
6
Mechanism of Androgen-Independent Stromal Proliferation in Benign Prostatic Hyperplasia.良性前列腺增生中雄激素非依赖性基质细胞增殖的机制。
Int J Mol Sci. 2023 Jul 19;24(14):11634. doi: 10.3390/ijms241411634.
7
Voiding function improves under long-term testosterone treatment (TTh) in hypogonadal men, independent of prostate size.长期睾酮治疗(TTh)可改善性腺功能低下男性的排尿功能,与前列腺体积无关。
Int Urol Nephrol. 2023 Jul;55(7):1649-1658. doi: 10.1007/s11255-023-03602-4. Epub 2023 May 6.
8
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios alone or combined with prostate-specific antigen for the diagnosis of prostate cancer and clinically significant prostate cancer.单独的中性粒细胞与淋巴细胞比值和血小板与淋巴细胞比值,或与前列腺特异性抗原联合用于诊断前列腺癌和临床显著性前列腺癌。
Asian J Urol. 2023 Apr;10(2):158-165. doi: 10.1016/j.ajur.2022.02.007. Epub 2022 Mar 5.
9
Effects of Alginate Oligosaccharide on Testosterone-Induced Benign Prostatic Hyperplasia in Orchiectomized Rats.藻寡糖对去势诱导的大鼠前列腺增生的影响。
Nutrients. 2023 Jan 29;15(3):682. doi: 10.3390/nu15030682.
10
Association between prostatic 18F-FDG uptake and lower urinary tract symptoms assessed by International Prostate Symptom Score.通过国际前列腺症状评分评估前列腺18F-FDG摄取与下尿路症状之间的关联。
Diagn Interv Radiol. 2022 Mar;28(2):179-184. doi: 10.5152/dir.2022.20677.